Amylyx Pharmaceuticals
(NASDAQ) AMLX
Amylyx Pharmaceuticals Financials at a Glance
Market Cap
$1.65B
Revenue (TTM)
$0.00
Net Income (TTM)
$144.74M
EPS (TTM)
$-1.55
P/E Ratio
-9.63
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$15.95
Volume
527,255.103
Open
$14.94
Price
$15.95
Volume
527,255.103
Open
$14.94
Previous Close
$14.95
Daily Range
$14.90 - $15.80
52-Week Range
$3.11 - $17.49
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$15.95
Volume
527,255.103
Open
$14.94
Previous Close
$14.95
Daily Range
$14.90 - $15.80
52-Week Range
$3.11 - $17.49
AMLX News
AMLX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amylyx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
136
CEO
Josh Cohen; Justin Klee
Website
www.amylyx.comHeadquarters
Cambridge, MA 02141, US
AMLX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-62%
Return on Capital
-49%
Return on Assets
-44%
Earnings Yield
-10.38%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.65B
Shares Outstanding
110.54M
Volume
527.26K
Short Interest
0.00%
Avg. Volume
1.26M
Financials (TTM)
Gross Profit
$525.00K
Operating Income
$153.29M
EBITDA
$144.16M
Operating Cash Flow
$123.34M
Capital Expenditure
$138.00K
Free Cash Flow
$123.48M
Cash & ST Invst.
$316.98M
Total Debt
$5.96M
Amylyx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+100.0%
Gross Profit
$108.00K
+83.8%
Gross Margin
0.00%
N/A
Market Cap
$1.65B
N/A
Market Cap/Employee
$13.44M
N/A
Employees
123
N/A
Net Income
$33.00M
+12.1%
EBITDA
$30.95M
+23.6%
Quarterly Fundamentals
Net Cash
$311.02M
+78.2%
Accounts Receivable
$88.00K
-80.3%
Inventory
$0.00
N/A
Long Term Debt
$4.70M
+914.7%
Short Term Debt
$1.26M
-17.1%
Return on Assets
-43.51%
N/A
Return on Invested Capital
-49.46%
N/A
Free Cash Flow
$27.99M
+52.6%
Operating Cash Flow
$27.90M
+52.7%